No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
BOXL Boxlight
- 0.5964
- -0.0236-3.81%
Close Jul 22 16:00 ET
- 0.5901
- -0.0063-1.05%
Post 16:17 ET
5.83MMarket Cap-127P/E (TTM)
0.6699High0.5900Low84.98KVolume0.6350Open0.6200Pre Close50.92KTurnover0.92%Turnover RatioLossP/E (Static)9.78MShares2.420052wk High0.64P/B5.50MFloat Cap0.490052wk Low--Dividend TTM9.23MShs Float139.2000Historical High--Div YieldTTM12.89%Amplitude0.4900Historical Low0.5990Avg Price1Lot Size
Post-Market
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Express News | Boxlight Corp: On July 2, 2024, Requested & Got Additional $2 Mln Working Capital Bridge Loan
Boxlight Wins 8 Best of Show Awards at ISTE 24
Boxlight Unveils FrontRow UNITY, a First-of-its-Kind Solution for Instruction, Campus Communication, and Safety
Boxlight Corporation (NASDAQ:BOXL) —recognized as one of the top ed-tech companies in the world for innovative solutions that enhance communication and collaboration in educational institutions and businesses— announces
Boxlight Maintains Its Commitment to Edtech Innovation, Unveiling a Range of New Solutions at ISTELive24
Boxlight Corporation (NASDAQ:BOXL)—recognized as one of the top ed-tech companies in the world for innovative solutions that enhance communication and collaboration in educational institutions and businesses—is
Express News | Boxlight Corp: Unanimously Removes Interim CEO Designation
Express News | Boxlight Appoints Dale Strang As CEO
Comments
$Boxlight(BOXL.US$
The earnings report is pretty bad compared to other years.. so expect a increase in the price because the stock market is retarded.
The earnings report is pretty bad compared to other years.. so expect a increase in the price because the stock market is retarded.
2
$Boxlight(BOXL.US$ Make sure you've got your Boxlight
2
The consensus update that leads to the downgrade of the revenue forecasts and an increase in losses per share for Boxlight has led to a shift in sentiment among analysts, which could make investors wary of the company.
$Lixte Biotechnology(LIXT.US$ 700k float / 60% institutional /67% CTB
$Grove Collaborative(GROV.US$ 16m float / 74% institutional/ 30% CTB
$Acorda Therapeutics(ACOR.US$ 1.2m float/ 18% institutional/ 37% CTB
$Verastem(VSTM.US$ 16m float / 40% institutional/ 18% CTB
$Cibus Inc(CBUS.US$ 16m float / 12% institutional
$Bone Biologics(BBLG.US$ 27m float / 17% institutional/ 127% CTB
$Greenlane(GNLN.US$ 1.5m float/ 17% institutional/ 35% CTB
$VistaGen Therapeutics(VTGN.US$ 7.2m floa...
$Grove Collaborative(GROV.US$ 16m float / 74% institutional/ 30% CTB
$Acorda Therapeutics(ACOR.US$ 1.2m float/ 18% institutional/ 37% CTB
$Verastem(VSTM.US$ 16m float / 40% institutional/ 18% CTB
$Cibus Inc(CBUS.US$ 16m float / 12% institutional
$Bone Biologics(BBLG.US$ 27m float / 17% institutional/ 127% CTB
$Greenlane(GNLN.US$ 1.5m float/ 17% institutional/ 35% CTB
$VistaGen Therapeutics(VTGN.US$ 7.2m floa...
41
22
$Boxlight(BOXL.US$ Short Only 🤩👍
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
8 Seconds : There is nothing wrong with those numbers. They beat estimates on both revenues and losses. What's bad about the earnings report?
8 Seconds : I do agree, however, that the stock price will increase.